Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices 8215 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Alexander Yakovlev, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5206, 

MSC 7846, Bethesda, MD 20892–7846, 301– 

435–1254, yakovleva@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; Genetics 

of Health and Disease Study Section. 

Date: March 1–2, 2021. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Christopher Payne, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Rm. 2208, 

Bethesda, MD 20892, 301–402–3702, 

christopher.payne@nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated Review 

Group; Cancer Immunopathology and 

Immunotherapy Study Section. 

Date: March 1–2, 2021. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Zhang-Zhi Hu, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6186, 

MSC 7804, Bethesda, MD 20892, (301) 594– 

2414, huzhuang@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Health Services: Quality and Effectiveness 

Study Section. 

Date: March 1–2, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Shalanda A. Bynum, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3206, 

Bethesda, MD 20892, 301–755–4355, 

bynumsa@csr.nih.gov. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group; Drug Discovery and Molecular 

Pharmacology Study Section. 

Date: March 1–2, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jeffrey Smiley, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6194, 

MSC 7804, Bethesda, MD 20892, 301–594– 

7945, smileyja@csr.nih.gov. 

Name of Committee: Oncology 1—Basic 

Translational Integrated Review Group; 

Cancer Etiology Study Section. 

Date: March 1, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sarita Kandula Sastry, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20782, 301–402–4788, sarita.sastry@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 26, 2021. 

Ronald J. Livingston, Jr., 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–02291 Filed 2–3–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Frederick National 

Laboratory Advisory Committee to the 

National Cancer Institute. 

The meeting will be held virtually 

and is open to the public. Individuals 

who plan to view the virtual meeting 

and need special assistance or other 

reasonable accommodations to view the 

meeting, should notify the Contact 

Person listed below in advance of the 

meeting. The meeting will be videocast 

and can be accessed from the NIH 

Videocasting and Podcasting website 

(http://videocast.nih.gov/). 

Name of Committee: Frederick National 

Laboratory Advisory Committee to the 

National Cancer Institute. 

Date: February 23, 2021. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: Ongoing and new activities at the 

Frederick National Laboratory for Cancer 

Research. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Rockville, 

MD 20850 (Virtual Meeting). 

Contact Person: Caron A. Lyman, Ph.D., 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 9609 

Medical Center Drive, Room 7W126, 

Bethesda, MD 20892–9750, 240–276–6348, 

lymanc@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/fac/fac.htm, 

where an agenda, instructions for access, and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 29, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–02313 Filed 2–3–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; GEMSSTAR. 

Date: March 1, 2021. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Isis S. Mikhail, MD, MPH, 

DrPH, Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

National Institutes of Health, Gateway 

Building 2C212, 7201 Wisconsin Avenue, 


jbell on DSKJLSW7X2PROD with NOTICES
8216 Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices 

Bethesda, MD 20892, 301–402–7704, 

mikhaili@mail.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Trauma 

Exposure and Cognitive Decline in Brain 

Aging. 

Date: March 3, 2021. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Rajasri Roy, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, National 

Institutes of Health, Gateway Building 

2W200, 7201 Wisconsin Avenue, Bethesda, 

MD 20892, (301) 496–6477, rajasri.roy@

nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Age-related 

traits In SardiNIA5. 

Date: March 5, 2021. 

Time: 3:30 p.m. to 5:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Maurizio Grimaldi, MD, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

National Institutes of Health, 7201 Wisconsin 

Avenue, Gateway Building, Suite 2W200, 

Bethesda, MD 20892, 301–496–9374, 

grimaldim2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: January 29, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–02310 Filed 2–3–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; A Generic 

Submission for Formative Research, 

Pre-Testing, Stakeholder Measures 

and Advocate Forms at NCI (National 

Cancer Institute) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Amy Williams, Director of the Office of 

Advocacy Relations (OAR), NCI, NIH, 

31 Center Drive, Bldg. 31, Room 10A28, 

MSC 2580, Bethesda, MD 20892, call 

non-toll-free number 240–781–3406, or 

email your request, including your 

address, to amy.williams@nih.gov. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on October 8, 2020, page 63565 

(Vol. 85 FR 63565) and allowed 60 days 

for public comment. No public 

comments were received. The National 

Cancer Institute (NCI), National 

Institutes of Health, may not conduct or 

sponsor, and the respondent is not 

required to respond to, an information 

collection that has been extended, 

revised, or implemented on or after 

October 1, 1995, unless it displays a 

currently valid OMB control number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection: A Generic 

Submission for Formative Research, Pretesting, Stakeholder Measures and 

Advocate Forms at NCI, OMB #0925– 

0641: Expiration Date 1/31/2021, 

Reinstatement Without Change. 

National Cancer Institute (NCI), 

National Institutes of Health (NIH). 

Need and Use of Information 

Collection: The Office of Advocacy 

Relations (OAR) disseminates cancerrelated information to a variety of 

stakeholders, seeks input and feedback, 

and facilitates collaboration to advance 

NCI’s authorized programs. It is 

beneficial for NCI, through the OAR, to 

pretest strategies, concepts, activities 

and materials while they are under 

development. Additionally, 

administrative forms are a necessary 

part of collecting demographic 

information and areas of interest for 

advocates. Since OAR is responsible for 

matching advocates to NCI programs 

and initiatives across the cancer 

continuum, it is necessary to measure 

the satisfaction of both internal and 

external stakeholders with this 

collaboration. This customer satisfaction 

research helps ensure the relevance, 

utility, and appropriateness of the many 

initiatives and products that OAR and 

NCI produce. The OAR will use a 

variety of qualitative (interviews) 

methodology to conduct this research, 

allowing NCI to: (1) Understand 

characteristics (attitudes, beliefs, and 

behaviors) of the intended target 

audience and use this information in the 

development of effective strategies, 

concepts, activities; (2) use a feedback 

loop to help refine, revise, and enhance 

OAR’s efforts—ensuring that they have 

the greatest relevance, utility, 

appropriateness, and impact for/to 

target audiences; and (3) expend limited 

program resource dollars wisely and 

effectively. The anticipated respondents 

will consist of adult cancer research 

advocates; members of the public; 

health care professionals; and 

organizational representatives. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

18. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of 

respondent 

Number of 

respondents 

Number of 

responses per 

respondent 

Average time 

per response 

(in hours) 

Total annual 

burden hour 

In-Depth Interviews ........................... Individuals ......................................... 6 1 30/60 3 

Profile Completion ............................ Individuals ......................................... 30 1 30/60 15 

Totals ......................................... ........................................................... ........................ 36 ........................ 18 


jbell on DSKJLSW7X2PROD with NOTICES